(MedPage Today) — The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced.
The subcutaneous anti-interleukin…
Cate Blanchett knows how to make a statement on the red carpet, but her most recent look was reminiscent of...
Extra caution should guide international responses to Ebola outbreak Source: www.thehindu.com Medical Disclaimer: This content is shared for informational and...
‘Local health outbreak can now turn global in days’: Expert on pandemic preparedness Source: indianexpress.com
Heir to Thai beer empire Singha sacked after brother's abuse accusations Source: www.channelnewsasia.com
The top court warned of contempt for non-compliance Source: www.thehindu.com Medical Disclaimer: This content is shared for informational and educational...
No vaccine or therapeutic treatment exists for the Bundibugyo strain of Ebola responsible for the latest outbreak of the disease,...
